Skip to main content
The words approved in red and spelled out in capitals.

Lupin receives FDA OK for generic Truvada

Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of roughly $2.1 billion.
Levy

Lupin has received the Food and Drug Administration’s nod for emtricitabine and tenofovir disoproxil fumarate tablets in a dosage strength of 200 mg/300 mg.

The medication is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection.

The product, the generic of Gilead Sciences’ Truvada tablets, will be manufactured at the company's facility in Nagpur.

Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of roughly $2.1 billion.

X
This ad will auto-close in 10 seconds